Kuhathasan, Nirushi
Minuzzi, Luciano
MacKillop, James
Frey, Benicio N.
Article History
Received: 6 December 2021
Accepted: 21 April 2022
First Online: 28 April 2022
Declarations
:
: Ethics approval for this research was granted by the Hamilton Integrated Research Ethics Board (HiREB project #7162). The study was designed to be compliant with the Health and Information Protection Act, 2016 (HIPA). All methods were performed in accordance with the relevant guidelines and regulations. Informed consent was collected through Strainprint® and all subjects provided consent to share their information for research purposes.
: Not applicable.
: JM is a principal in BEAM Diagnostics, Inc. and a Consultant to Clairvoyant Therapeutics, Inc. NK, LM and BNF have no competing interests to declare.